Correlation Between Acurx Pharmaceuticals and Immutep
Can any of the company-specific risk be diversified away by investing in both Acurx Pharmaceuticals and Immutep at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Acurx Pharmaceuticals and Immutep into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Acurx Pharmaceuticals LLC and Immutep Ltd ADR, you can compare the effects of market volatilities on Acurx Pharmaceuticals and Immutep and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Acurx Pharmaceuticals with a short position of Immutep. Check out your portfolio center. Please also check ongoing floating volatility patterns of Acurx Pharmaceuticals and Immutep.
Diversification Opportunities for Acurx Pharmaceuticals and Immutep
0.06 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Acurx and Immutep is 0.06. Overlapping area represents the amount of risk that can be diversified away by holding Acurx Pharmaceuticals LLC and Immutep Ltd ADR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Immutep Ltd ADR and Acurx Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Acurx Pharmaceuticals LLC are associated (or correlated) with Immutep. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Immutep Ltd ADR has no effect on the direction of Acurx Pharmaceuticals i.e., Acurx Pharmaceuticals and Immutep go up and down completely randomly.
Pair Corralation between Acurx Pharmaceuticals and Immutep
Given the investment horizon of 90 days Acurx Pharmaceuticals LLC is expected to under-perform the Immutep. In addition to that, Acurx Pharmaceuticals is 1.55 times more volatile than Immutep Ltd ADR. It trades about -0.21 of its total potential returns per unit of risk. Immutep Ltd ADR is currently generating about -0.01 per unit of volatility. If you would invest 231.00 in Immutep Ltd ADR on September 15, 2024 and sell it today you would lose (13.00) from holding Immutep Ltd ADR or give up 5.63% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Acurx Pharmaceuticals LLC vs. Immutep Ltd ADR
Performance |
Timeline |
Acurx Pharmaceuticals LLC |
Immutep Ltd ADR |
Acurx Pharmaceuticals and Immutep Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Acurx Pharmaceuticals and Immutep
The main advantage of trading using opposite Acurx Pharmaceuticals and Immutep positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Acurx Pharmaceuticals position performs unexpectedly, Immutep can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immutep will offset losses from the drop in Immutep's long position.Acurx Pharmaceuticals vs. Aerovate Therapeutics | Acurx Pharmaceuticals vs. Adagene | Acurx Pharmaceuticals vs. Acrivon Therapeutics, Common | Acurx Pharmaceuticals vs. Rezolute |
Immutep vs. Ocean Biomedical | Immutep vs. Elevation Oncology | Immutep vs. Zura Bio Limited | Immutep vs. Cns Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Complementary Tools
CEOs Directory Screen CEOs from public companies around the world | |
Stocks Directory Find actively traded stocks across global markets | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |